首页> 外文期刊>Current Science: A Fortnightly Journal of Research >A comparative study to elucidate the inhibitory mechanism of a 6-mer fragment of amyloid-beta 42 peptide as a potential therapeutic in Alzheimer's disease: insights from molecular dynamics simulations
【24h】

A comparative study to elucidate the inhibitory mechanism of a 6-mer fragment of amyloid-beta 42 peptide as a potential therapeutic in Alzheimer's disease: insights from molecular dynamics simulations

机译:阐明淀粉样蛋白β2222肽的6-MER片段抑制机制作为阿尔茨海默病的潜在治疗方法的对比研究:分子动力学模拟的见解

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Alzheimer's disease is a neurodegenerative and incurable disease that is associated with the amyloid beta (A beta) aggregation. We have carried out comparative molecular dynamics simulations of a 6-mer peptide and its analogues to elucidate the inhibitory mechanism on A. aggregation. The top analogue screened after refinement via docking exhibited significant inhibitory activities on both A beta(17-42) fibril as well as A beta(1-42) monomer, leading to disassembly of beta-strands of A beta(1-42) peptide and fibril by interacting with C-terminal residues via hydrogen bonds and hydrophobic contacts. Binding of the analogue to the C-terminal region proves to be significant.
机译:阿尔茨海默病是一种神经变性和可治区疾病,与淀粉样蛋白β(β)聚集有关。 我们已经进行了6-MER肽的比较分子动力学模拟及其类似物以阐明A的抑制机制。聚集。 通过对接的细化后筛选的顶部类似物在β(17-42)原纤维以及β(1-42)单体上表现出显着的抑制活性,导致β-链的β-链(1-42)肽 通过通过氢键和疏水触点与C末端残基相互作用来纤维。 模拟与C末端区域的结合证明是显着的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号